SUBSCRIBERS

Hyphens inks MOU with A*Star's A*ccelerate

The five-year commercialisation deal covers development of products targeting eczema, acne, pigmentary disorders

Published Thu, Mar 21, 2019 · 09:50 PM
Share this article.

Singapore

SGX Catalist-listed Hyphens Pharma International Limited signed a Memorendum of Understanding (MOU) with A*Star's commercial arm A*ccelerate, previously known as Exploit Technologies, at the opening ceremony of its corporate headquarters and integrated facility in Singapore on Wednesday.

Lim See Wah, Hyphen Pharma's chairman and CEO, said: "Our new corporate headquarters and integrated facility will not only provide enhanced efficiency and productivity, it will also serve as an oasis for our people to germinate creative and innovative ideas."

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to  t.me/BizTimes

Companies & Markets

SUPPORT SOUTH-EAST ASIA'S LEADING FINANCIAL DAILY

Get the latest coverage and full access to all BT premium content.

SUBSCRIBE NOW

Browse corporate subscription here